Panel Critiques TAG Graft Study Size, But Deems Approval “Common Sense”

The appeal of WL Gore's TAG thoractic endograft as a less-invasive alternative to open-heart surgery swayed FDA panelists to recommend device approval Jan. 13

More from Archive

More from Medtech Insight